Literature DB >> 3180379

Regional myocardial free fatty acid extraction in normal and ischemic myocardium.

K Vyska1, H J Machulla, W Stremmel, D Fassbender, W H Knapp, G Notohamiprodjo, U Gleichmann, H Meyer, E J Knust, R Körfer.   

Abstract

The rate constant for free fatty acid influx (k1) was studied in normal and ischemic myocardium. In 15 normal subjects and 30 patients with coronary artery disease, 201Tl and 15-(p-123I-iodophenyl)-pentadecanoic acid (IPPA) were administered during exercise under fasting conditions and at rest. In 10 patients, the study was repeated after percutaneous transluminal coronary angioplasty; in three patients, the study was repeated after infarction. The initial accumulation of IPPA, related to that of 201Tl (both background and crossover corrected), was used for determinations of the regional rate constant of IPPA influx into myocardial tissue (k1*). In normal subjects, no significant differences in k1* between major myocardial segments were found; the average value of k1* was 0.57 +/- 0.13/min (mean +/- SD) at rest and 0.42 +/- 0.06/min at exercise (average workload, 123 +/- 47 W). With increasing free fatty acid plasma concentration and perfusion, free fatty acid influx increased in a saturable fashion. The Michaelis-Menten constant (KM*) and the maximal velocity (Vmax*) for IPPA influx into myocardial tissue were estimated to be 470 nmol/g and 430 nmol/g.min, respectively. In ischemic areas, k1* was reduced to 57 +/- 18% of k1* value in nonaffected segments. The areas were larger than those showing reduced 201Tl uptake. Preinfarction and postinfarction studies showed that the size of 201Tl defects in postinfarction images corresponded with the size of the area with reduced k1* observed in preinfarction scintigrams. Revascularization led to an increase of 201Tl uptake and to normalization of k1*.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180379     DOI: 10.1161/01.cir.78.5.1218

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  18 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

Review 2.  Tracers for metabolic imaging of brain and heart. Radiochemistry and radiopharmacology.

Authors:  G Stöcklin
Journal:  Eur J Nucl Med       Date:  1992

Review 3.  Nuclear medicine to image applied pathophysiology: evaluation of reserves by emission computerized tomography.

Authors:  U Buell; H Schicha
Journal:  Eur J Nucl Med       Date:  1990

Review 4.  Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.

Authors:  A Syrota; P Jehenson
Journal:  Eur J Nucl Med       Date:  1991

5.  Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study.

Authors:  J Kropp
Journal:  Eur J Nucl Med       Date:  1993-04

Review 6.  Transmembrane transport of fatty acids in the heart.

Authors:  W Stremmel
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

7.  The metabolism of 15-p-[123I]-iodophenylpentadecanoic acid in a surgically induced canine model of regional ischemia.

Authors:  M P Hudon; D M Lyster; W R Jamieson; A K Qayumi; C Sartori; H Dougan
Journal:  Eur J Nucl Med       Date:  1990

8.  Correlation of heterogeneous blood flow and fatty acid uptake in the normal dog heart.

Authors:  A B Groeneveld; F C Visser
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

9.  Patency of the infarct-related coronary artery--a pertinent factor in late recovery of myocardial fatty acid metabolism among patients receiving thrombolytic therapy?

Authors:  M Walamies; V Virtanen; M Koskinen; A Uusitalo
Journal:  Eur J Nucl Med       Date:  1994-09

Review 10.  Physical activity and lipoprotein lipid disorders.

Authors:  A Berg; I Frey; M W Baumstark; M Halle; J Keul
Journal:  Sports Med       Date:  1994-01       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.